In 2022, the global orthopedic biomaterials device market was valued at $5.6 billion. This is anticipated to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.
The full report suite on the global market for orthopedic biomaterials includes bone graft substitutes, growth factors, cell therapy, hyaluronic acid viscosupplementation and cartilage repair (appendix only).
MARKET REPORT DATA TYPES INCLUDED:
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2028, and Historical Data to 2018
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL ORTHOPEDIC BIOMATERIALS MARKET TRENDS
By the year 2030, elder persons are anticipated to outnumber children under the age of 10 (1.41 billion versus 1.35 billion), and, by 2050, projections indicate that there will be a greater number of persons aged 60 or over than adolescents aged 10-24 (2.1 billion versus 2.0 billion). The aging of the population will significantly impact the orthopedic biomaterials device market, increasing the prevalence of bone diseases and the need for treating them. However, orthopedic biomaterials device markets were negatively impacted by COVID-19 in the short term due to mass cancellations and postponements of procedures across all countries.
GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS
Overall, within the Global orthopedic biomaterials market there are three leading competitors: Medtronic, DePuy Synthes, and Stryker. Medtronic has maintained a strong presence in the total orthopedic Biomaterials device market through a variety of characteristics including brand recognition, strong customer support and a large sales force. The company held the largest share of the orthopedic bone graft substitute segment and dominated in the orthopedic growth factor market because of the success of its INFUSE™ product.
MARKET SEGMENTATION SUMMARY
You can view all these included reports and segmentation here:
- Orthopedic Bone Graft Substitutes Market - MedCore - Includes:
- Allograft BGS, demineralized bone matrix allograft BGS and synthetic BGS.
- Orthopedic Growth Factor Market - MedCore
- Orthopedic Cell Therapy Market - MedCore - Includes:
- Platelet-rich plasma and bone marrow therapy segments.
- Hyaluronic Acid Viscosupplementation Market - MedCore - Includes:
- Single-injection, Two-injection, Three-Injection, and Five-Injection products.
- In Appendix* Orthopedic Cartilage Repair Market - MedCore - Includes:
- Osteochondral allografts, meniscal allografts, and autologous chondrocytes.
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast: 2023-2029
- Historical Data: 2019-2022
- Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
- Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.